NATR
Next earnings: Jul 30, 2026 · After close
Signal
Leaning Bearish1
Price
1
Move-0.27%Quiet session
Volume
1
Volume0.9× avgNormal activity
Technical
1
RSIRSI 37Momentum negative
PRICE
Prev Close
22.28
Open
22.09
Day Range21.91 – 22.83
21.91
22.83
52W Range12.97 – 28.14
12.97
28.14
61% of range
VOLUME & SIZE
Avg Volume
109.0K
FUNDAMENTALS
P/E Ratio
20.2x
EPS (TTM)
Div Yield
No dividend
Beta
0.58
Low vol
Performance
1D
-0.27%
5D
-12.90%
1M
-15.83%
3M
-17.43%
6M
+4.96%
YTD
+2.97%
1Y
+51.26%
Best: 1Y (+51.26%)Worst: 3M (-17.43%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +7% YoY · 72% gross margin
Valuation
FAIR
P/E 20x vs ~20x sector
Health
STRONG
CR 2.5 · FCF $1.31/sh
Strong Buy
Key MetricsTTM
Market Cap$390.74M
Revenue TTM$489.79M
Net Income TTM$19.89M
Free Cash Flow$23.02M
Gross Margin72.0%
Net Margin4.1%
Operating Margin5.7%
Return on Equity12.3%
Return on Assets7.6%
Debt / Equity0.13
Current Ratio2.50
EPS TTM$1.14
Alpha SignalsFull Analysis →
What Moves This Stock

Active distributor count growth or contraction - the lifeblood of MLM revenue generation

Average order value and purchase frequency among existing distributors (same-store sales proxy)

Geographic revenue mix shifts - Asia-Pacific typically delivers higher margins than mature North American market

Regulatory developments affecting MLM business models in key markets (China, US, Europe)

Macro Sensitivity
Economic Cycle

moderate - Nutritional supplements exhibit defensive characteristics as health-conscious consumers maintain spending during downturns, but the MLM model creates cyclical exposure through distributor income sensitivity. Distributors often treat sales as supplemental income, and recruitment slows when primary employment weakens. Discretionary personal care products face more pressure than core vitamins during recessions. International markets (40%+ of revenue) add GDP sensitivity across diverse economies.

Interest Rates

Low direct impact as the company carries minimal debt (0.09 D/E ratio) and generates positive operating cash flow. However, rising rates indirectly affect distributor financing for inventory purchases and reduce consumer discretionary spending power. Valuation multiples compress in rising rate environments, particularly for low-growth consumer stocks trading at 1.0x sales.

Key Risks

Regulatory risk to MLM business model - FTC scrutiny of pyramid scheme characteristics, China's evolving direct sales regulations, and potential restrictions on health claims could fundamentally impair the distribution model

E-commerce disruption - Amazon and direct-to-consumer brands bypass MLM economics, offering comparable supplements at lower prices with greater convenience, eroding the value proposition of distributor relationships

Demographic shifts - younger consumers show less receptivity to MLM purchasing models, preferring digital-native brands and subscription services

Investor Profile

momentum - The 86% one-year return and 62% six-month return attract technical traders and momentum investors despite weak fundamentals (2% revenue growth, -49% net income decline). The micro-cap size ($500M market cap) and low institutional ownership typical of MLM stocks draw retail speculation. Value investors may be attracted to 1.0x sales and 9.2x EV/EBITDA if turnaround story materializes, but deteriorating profitability (-48% EPS decline) limits traditional value appeal.

Watch on Earnings
USD/CNY exchange rate (DEXCHUS) - China represents significant Asia-Pacific revenue exposureUS consumer sentiment (UMCSENT) - drives discretionary wellness spending and distributor recruitmentPersonal savings rate (PSAVERT) - higher savings reduces discretionary supplement purchasesRetail sales ex-auto (RSXFS) - proxy for overall consumer spending health
Health Radar
4 strong2 watch
75/100
Liquidity
2.50Strong
Leverage
0.13Strong
Coverage
326.9xStrong
ROE
12.3%Watch
ROIC
9.7%Watch
Cash
$94MStrong
ANALYST COVERAGE3 analysts
BUY
+66.5%upside to target
Buy
267%
Hold
133%
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 37 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 2.50 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 27, 2026
In 103 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 26.9%

-11.7% vs SMA 50 · +12.1% vs SMA 200

Momentum

RSI36.6
Momentum fading
MACD-0.63
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$28.14+26.6%
EMA 50
$24.10+8.4%
Current
$22.22
EMA 200
$19.88-10.5%
52W Low
$12.97-41.6%
52-Week RangeMid-range
$12.9761th %ile$28.14
Squeeze SetupVolume-based
Distribution Pressure

Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.

20-Day Money Flow
Acc days:0
Dist days:4
Edge:+4 dist
Volume Context
Avg Vol (50D)108K
Recent Vol (5D)
118K+9%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 2 analysts
Analyst revisions:EPS↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$441.7M
$440.7M$442.6M
$0.82
±0%
Low1
FY2024
$445.5M
$445.1M$445.9M
+0.9%$0.66-19.2%
±0%
Low2
FY2025
$477.8M
$477.2M$478.4M
+7.3%$1.15+74.0%
±0%
Low2
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 5 consecutive quarters
Earnings HistoryNATR
Last 8Q
+27.7%avg beat
Beat 6 of 8 quartersMissed 2
-72%
Q3'24
+64%
Q4'24
-110%
Q1'25
+47%
Q2'25
+94%
Q3'25
+89%
Q4'25
+62%
Q1'26
+46%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Yates Bryant JEVP & Presiden…
$475K
Mar 13
SELL
Norman Daniel CEVP & Presiden…
$377K
Mar 13
SELL
Lanoy Jonathan DavidSVP, Chief Acc…
$99K
Mar 13
SELL
Yates Bryant JEVP & Presiden…
$38K
Dec 12
SELL
Norman Daniel CEVP & Presiden…
$182K
Nov 12
SELL
Lanoy Jonathan DavidSVP, Chief Acc…
$102K
Nov 18
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
1.8M
2
BlackRock, Inc.
1.1M
3
DIMENSIONAL FUND ADVISORS LP
895K
4
KENNEDY CAPITAL MANAGEMENT LLC
691K
5
ACADIAN ASSET MANAGEMENT LLC
658K
6
RENAISSANCE TECHNOLOGIES LLC
532K
7
Hillsdale Investment Management Inc.
317K
8
Boston Partners
220K
News & Activity

NATR News

20 articles · 4h ago

About

Nature's Sunshine Products, a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today.

Industry
Pharmaceutical Preparation Manufacturing
Nathan G. BrowerExecutive Vice President, General Counsel & Secretary
Trent McCauslandVice President of Global Impact & Sustainability
Erich A. FritzExecutive Vice President of Global Supply Chain
PeersConsumer Defensive(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
NATR
$22.22-0.27%$391M19.6+567.4%1500
$131.45-0.76%$1.0T47.9+472.5%307.0%1520
$1048.95+0.74%$465.4B54.5+816.7%294.3%1507
$80.82+0.46%$347.7B25.4+187.0%2734.0%1508
$141.57-0.80%$329.7B20.5+29.2%1895.3%1486
$189.61-1.17%$295.5B26.7+731.3%2791.8%1509
$149.12+0.30%$203.8B23.3+225.5%877.3%1488
Sector avg-0.21%31.1+432.8%1483.3%1503